@article{BoelchStreckPlumhoffetal.2020,
  author    = {Boelch, Sebastian Philipp and Streck, Laura Elisa and Plumhoff, Piet and Konrads, Christian and Gohlke, Frank and Rueckl, Kilian},
  title     = {Infection control and outcome of staged reverse shoulder arthroplasty for the management of shoulder infections},
  series = {JSES International},
  volume    = {4},
  journal   = {JSES International},
  doi       = {10.1016/j.jseint.2020.08.012},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-230620},
  pages     = {959-963},
  year      = {2020},
  abstract  = {Background The treatment of septic arthritis, caused by either hematogenous seeding, injections, or surgery, can be challenging. Staged reverse shoulder arthroplasty (RSA) with temporary implantation of an antibiotic-loaded spacer is widely accepted but still discussed controversially. This study investigated the shoulder-specific bacterial spectrum, infection control rate, functional outcome, and infection-free survival rate after staged RSA in the mid- to long-term follow-up. It was hypothesized that staged RSA would show a high infection-free survival rate. Methods A total of 39 patients treated with staged RSA for primary septic arthritis (n = 8), secondary infection (n = 8), or periprosthetic infection (n = 23) were retrospectively included. The infection control rate was calculated based on cultures taken intraoperatively at spacer removal and RSA implantation. Infection-free survival was defined as no revision due to infection. The minimum follow-up period for functional outcome assessment was 2 years (n = 14; mean, 76 months; range, 31-128 months). Results Cutibacterium (26\%) and coagulase-negative staphylococci (23\%) were the predominant pathogens. The infection control rate was 90\%. The cumulative infection-free survival rate was 91\% after 128 months. Follow-up examinations showed a mean Constant score of 48 (range, 7-85), a mean QuickDASH (short version of Disabilities of the Arm, Shoulder and Hand questionnaire) score of 40.0 (range, 11.4-93.3), and a mean pain score of 1.6 (range, 0-7). Conclusion Staged RSA implantation was confirmed to be a reliable treatment option for primary, secondary, and periprosthetic infections of the shoulder. The infection control rate and infection-free survival rate are satisfactory. However, patients and surgeons must be aware of functional impairment even after successful treatment of infections.},
  language  = {en}
}
@article{BoelchRueecklStrecketal.2021,
  author    = {Boelch, Sebastian Philipp and R{\"u}eckl, Kilian and Streck, Laura Elisa and Szewczykowski, Viktoria and Weißenberger, Manuel and Jakuscheit, Axel and Rudert, Maximilian},
  title     = {Diagnosis of chronic infection at total hip arthroplasty revision is a question of definition},
  series = {Biomed Research International},
  volume    = {2021},
  journal   = {Biomed Research International},
  doi       = {10.1155/2021/8442435},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-265762},
  year      = {2021},
  abstract  = {Purpose. Contradicting definitions of periprosthetic joint infection (PJI) are in use. Joint aspiration is performed before total hip arthroplasty (THA) revision. This study investigated the influence of PJI definition on PJI prevalence at THA revision. Test quality of prerevision aspiration was evaluated for the different PJI definitions. Methods. 256 THA revisions were retrospectively classified to be infected or not infected. Classification was performed according to the 4 different definitions proposed by the Musculoskeletal Infection Society (MSIS), the Infectious Diseases Society of America (IDSA), the International Consensus Meeting (ICM), and the European Bone and Joint Infection Society (EBJIS). Only chronic PJIs were included. Results. PJI prevalence at revision significantly correlated with the applied PJI definition (p=0.01, Cramer's V=0.093). PJI prevalence was 20.7\% for the MSIS, 25.4\% for the ICM, 28.1\% for the IDSA, and 32.0\% for the EBJIS definition. For synovial fluid white blood cell count, the best ROC-AUC for predicting PJI was 0.953 in combination with the MSIS definition. Conclusion. PJI definition significantly influences the rate of diagnosed PJIs at THA revision. Synovial fluid white blood cell count is a reliable means to rule out PJI. In cases with a borderline high synovial white blood cell count before THA revision as the only sign of chronic PJI, an extended diagnostic work-up should be considered.},
  language  = {en}
}